Pharmaceutical companies have traditionally been very risk-averse and have adopted safe and well-established processes. This probably has its roots in the fact that the regulatory agencies in general have been very conservative and less approving of novel methodologies being used in the process unless absolutely necessary.
However, this is now changing. With the growing complexity of drug molecules and the need to involve newer and harsher reaction conditions that were once thought of as unfriendly in process chemistry, continuous flow chemistry and processing offer a proven alternative pathway.
Download our white paper to gain insights on:
- Transition from batch to continuous flow.
- Advantages of continuous flow chemistry.
- Regulatory compliance and quality by design (QbD) principles.
- Case studies and practical implementation of continuous flow processes.
Ready to move from idea to impact?
Whether you have a question for our team or an opportunity you’re eager to pursue, one of our experts can help you get started.
Contact Us